{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:25:54Z","timestamp":1776741954456,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s13181-019-00705-2","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T14:03:17Z","timestamp":1555077797000},"page":"143-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Relationship Between Circulating Acetaminophen-Protein Adduct Concentrations and Alanine Aminotransferase Activities in Patients With and Without Acetaminophen Overdose and Toxicity"],"prefix":"10.1007","volume":"15","author":[{"name":"The Acetaminophen Adduct Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Curry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Padilla-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Michelle","family":"Ruha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayrn D.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana G.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Jaeschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Wilhelms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Gerkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"7","key":"705_CR1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1517\/17425255.2014.920823","volume":"10","author":"MR McGill","year":"2014","unstructured":"McGill MR, Jaeschke H. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin Drug Metab Toxicol. 2014;10(7):1005\u201317.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"705_CR2","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1172\/JCI59755","volume":"122","author":"MR McGill","year":"2012","unstructured":"McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest. 2012;122(4):1574\u201383.","journal-title":"J Clin Invest"},{"issue":"1","key":"705_CR3","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/s41467-017-01970-x","volume":"8","author":"L Barbier-Torres","year":"2017","unstructured":"Barbier-Torres L, Iruzubieta P, Fern\u00e1ndez-Ramos D, Delgado TC, Taibo D, Guitierrez-de-Juan V, et al. The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury. Nat Commun. 2017 Dec;8(1):2068.","journal-title":"Nat Commun"},{"key":"705_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-230X-11-20","volume":"11","author":"KJ Heard","year":"2011","unstructured":"Heard KJ, Green JL, James LP, Judge BS, Zolot L, Rhyee S, et al. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol. 2011 Mar;11:20.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"705_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1124\/dmd.108.026195","volume":"37","author":"LP James","year":"2009","unstructured":"James LP, Letzig LG, Simpson PM, Capparelli E, Roberts DW, Hinson JA, et al. Pharmacokinetics of acetaminophen protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos. 2009;37(8):1779\u201384.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"705_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cgh.2016.09.007","volume":"15","author":"DW Roberts","year":"2017","unstructured":"Roberts DW, Lee WM, Hinson JA, Bai S, Swearingen CJ, Stravitz RT, et al. An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure. Clin Gastroenterol Hepatol. 2017;15(4):555\u201362.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"705_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.24060","volume":"53","author":"N Khandelwal","year":"2011","unstructured":"Khandelwal N, James LP, Sanders C, Larson AM, Lee WM. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology. 2011;53(2):567\u201376.","journal-title":"Hepatology"},{"issue":"3","key":"705_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"DW Kaufman","year":"2002","unstructured":"Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337\u201344.","journal-title":"JAMA"},{"issue":"3","key":"705_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.taap.2013.03.026","volume":"269","author":"MR McGill","year":"2013","unstructured":"McGill MR, Lebofsky M, Norris HR, Slawson MH, Bajt ML, Xie Y, et al. Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose\u2013response, mechanisms, and clinical implications. Toxicol Appl Pharmacol. 2013;269(3):240\u20139.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"705_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s13181-014-0431-2","volume":"11","author":"SC Curry","year":"2015","unstructured":"Curry SC, Padilla-Jones A, O\u2019Connor AD, Ruha AM, Bikin DS, Wilkins DG, et al. Prolonged acetaminophen-protein adduct elimination during renal failure, lack of adduct removal by hemodiafiltration, and urinary adduct concentrations after acetaminophen overdose. J Med Toxicol. 2015;11(2):169\u201378.","journal-title":"J Med Toxicol"},{"issue":"5","key":"705_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/1556-4029.13169","volume":"61","author":"KC Thomas","year":"2016","unstructured":"Thomas KC, Wilkins DG, Curry SC, Grey TC, Andrenyak DM, McGill LD, et al. Detection of acetaminophen\u2013protein adducts in decedents with suspected opioid\u2013acetaminophen combination product overdose. J Forensic Sci. 2016;61(5):1301\u20136.","journal-title":"J Forensic Sci"},{"issue":"3","key":"705_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/liv.13202","volume":"37","author":"JL Weemhoff","year":"2017","unstructured":"Weemhoff JL, Woolbright BL, Jenkins RE, McGill MR, Sharpe MR, Olson JC, et al. Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis. Liver Int. 2017;37(3):377\u201384.","journal-title":"Liver Int"},{"issue":"2","key":"705_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/toxsci\/kfu195","volume":"142","author":"BL Woolbright","year":"2014","unstructured":"Woolbright BL, McGill MR, Staggs VS, Winefield RD, Gholami P, Olyaee M, et al. Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. Toxicol Sci. 2014;142(2):436\u201344.","journal-title":"Toxicol Sci"},{"issue":"33","key":"705_CR14","doi-asserted-by":"publisher","first-page":"12169","DOI":"10.1073\/pnas.1412608111","volume":"111","author":"J Ward","year":"2014","unstructured":"Ward J, Kanchagar C, Veksler-Lublinsky I, Lee RC, McGill MR, Jaeschke H, et al. Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proc Natl Acad Sci U S A. 2014;111(33):12169\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"705_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/1354750X.2014.897757","volume":"19","author":"MR McGill","year":"2014","unstructured":"McGill MR, Cao M, Svetlov A, Sharpe MR, Williams CD, Curry SC, et al. Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers. 2014;19(3):222\u201330.","journal-title":"Biomarkers."},{"issue":"2","key":"705_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00204-013-1118-1","volume":"88","author":"MR McGill","year":"2014","unstructured":"McGill MR, Li F, Sharpe MR, Williams CD, Curry SC, Ma X, et al. Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch Toxicol. 2014;88(2):391\u2013401.","journal-title":"Arch Toxicol"},{"issue":"10","key":"705_CR17","first-page":"983","volume":"56","author":"L Tortora","year":"2018","unstructured":"Tortora L, Ruha M, Ramos K, Jaeschke H, Rumack B, Kang M, et al. Pharmacogenomic analysis of a patient with severe hepatotoxicity and hemolysis after acetaminophen overdose despite early N-acetylcysteine therapy. Clin Toxicol. 2018;56(10):983\u20134.","journal-title":"Clin Toxicol"},{"key":"705_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jchromb.2015.01.028","volume":"985","author":"SF Cook","year":"2015","unstructured":"Cook SF, King AD, Chang Y, Murray GJ, Norris HR, Dart RC, et al. Quantification of a biomarker of acetaminophen protein adducts in human serum by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry: clinical and animal model applications. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;985:131\u201341.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"705_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2310\/JIM.0b013e3181db8764","volume":"58","author":"B Gregory","year":"2010","unstructured":"Gregory B, Larson AM, Reisch J, Lee WM, Acute Liver Failure Study Group. Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med. 2010;58(5):707\u201310.","journal-title":"J Investig Med"},{"key":"705_CR20","doi-asserted-by":"crossref","unstructured":"McGill MR, Yan HM, Ramachandran A, Murray GJ, Rollins DE, Jaeschke H. HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology. 2011;53(3):974\u201382.","DOI":"10.1002\/hep.24132"},{"issue":"6","key":"705_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/clpt.2008.190","volume":"84","author":"LP James","year":"2008","unstructured":"James LP, Capparelli EV, Simpson PM, Letzig L, Roberts D, Hinson JA, et al. Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther. 2008 Dec;84(6):684\u201390.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00705-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-019-00705-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00705-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T23:29:21Z","timestamp":1586561361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-019-00705-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["705"],"URL":"https:\/\/doi.org\/10.1007\/s13181-019-00705-2","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"30 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Curry, Dr. Jaeschke, and Dr. Wilkins have had research activities supported by grants from McNeil Consumer Healthcare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}